AION Labs launches combinAble.AI to revolutionize antibody design with AI
In a bid to reshape the landscape of targeted antibody design, AION a creative venture studio based in Israel has introduced CombinAble.AI.
Archives for March 11, 2024
Medable's Colin Weller addresses challenges and future of clinical trials
A conversation between Colin Weller, VP and GM of the evidence platform at Medable and Liza Laws, senior editor, at Outsourcing Pharma, was held at this year’s SCOPE 2024 in Orlando.
Negev Capital fuels psychedelic medicine breakthroughs worldwide with three companies
Venture Capital firm, Negev Capital, holds a portfolio of companies creating neuropsychiatric drugs based on psychedelic molecules.
Pain is reduced by almost half with cannabis-based medicines – report finds
On March 7, Celadon Pharmaceuticals plc, a leading UK-based pharmaceutical company specializing in cannabis-based medicines, unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.